| Home |
| |
| Veeda Oncology® is
dedicated to providing clinical
oncology research services
internationally for the pharmaceutical and
biotech industries. With offices in the US,
Europe and India, Veeda Oncology is in the unparalleled position to meet both
the regional and global needs of our
sponsors. We are one of the few companies
whose main focus is oncology. As a result, Veeda Oncology can meet the
rigors of local and global requirements of
Phase I through Phase IV programs. |
| |
| Veeda Oncology Network |
| |
| On July 1, 2008 Veeda Oncology acquired
the assets of ION (International Oncology
Network) Clinical Research, assumed
responsibility for all of the clinical
trials underway and welcomed the ION
Clinical Research employees to Veeda
Oncology. ION Clinical Research was the
organization that managed all of the
oncology clinical trials in the ION Network.
In addition, Veeda Oncology entered into a
5-year exclusive agreement to manage all
oncology clinical trials that occur within
the ION network of sites. This agreement
gives Veeda Oncology access to over 110 ION
sites in the United States that conduct
clinical trials with screening possibilities
of over 100,000 new patients a year from
these sites. |
| |
| This tremendous network of sites not only
provides great access to patients for
clinical trials, but also significantly
reduces the time it takes to open a trial.
The average time to initiate a new trial
within the network is 2-3 months. |
| |
| What sets us apart from our competitors? |
| |
- Our oncology expertise is second to none.
- We use only leading-edge, industry-recognized systems.
- We have established relationships with oncology hospitals, which give us a unique ability to meet your patient accrual requirements.
- Our highly qualified staff is dedicated to investigational studies and will ensure that your specific project needs are met.
- Access to network of community oncology
sites.
|
| |